PLCO Publications
Here you can browse the complete list of publications for PLCO
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Randomized trials of PSA screening. | 38926075 | Dave P, Carlsson SV, Watts K | Urol Oncol | 2025 | PLCO |
| Higher insoluble fiber intake is associated with a lower risk of prostate cancer: results from the PLCO cohort. | 38243202 | Shen Y, Yuan Q, Shi M, Luo B | BMC Public Health | 2024 | PLCO |
| Prediction of prognosis and treatment response in ovarian cancer patients from histopathology images using graph deep learning: a multicenter retrospective study. | 38241820 | Yang Z, Zhang Y, Zhuo L, Sun K, Meng F, Zhou M, Sun J | Eur J Cancer | 2024 | PLCO |
| Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. | 38175578 | León-Letelier RA, Dou R, Vykoukal J, Yip-Schneider MT, Maitra A, Irajizad E, Wu R, Dennison JB, Do KA, Zhang J, Schmidt CM, Hanash S, Fahrmann JF | Clin Chem | 2024 | PLCO |
| Helicobacter hepaticus and Helicobacter bilis in liver and biliary cancers from ATBC and PLCO. | 38332674 | Murphy G, Freedman ND, Abnet CC, Albanes D, Cross AJ, Huang WY, Koshiol J, McGlynn K, Parisi D, Männistö S, Weinstein SJ, Waterboer T, Butt J | Helicobacter | 2024 | PLCO |
| Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort. | 38285606 | Byrd DA , Zouiouich S , Karwa S , Li XS , Wang Z , Sampson JN , Loftfield E , Huang WY , Hazen SL , Sinha R | Cancer | 2024 | PLCO |
| Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk. | 38308339 | Ünal P, Lu Y, Bueno-de-Mesquita B, van Eijck CHJ, Talar-Wojnarowska R, Szentesi A, Gazouli M, Kreivenaite E, Tavano F, Małecka-Wojciesko E, Erőss B, Oliverius M, Bunduc S, Nóbrega Aoki M, Vodickova L, Boggi U, Giaccherini M, Kondrackiene J, Chammas … | Hum Genomics | 2024 | PLCO |
| Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study. | 38280379 | Yamazaki H, Streicher SA, Wu L, Fukuhara S, Wagner R, Heni M, Grossman SR, Lenz HJ, Setiawan VW, Le Marchand L, Huang BZ | Cell Rep Med | 2024 | PLCO |
| Elucidating the role of blood metabolites on pancreatic cancer risk using two-sample Mendelian randomization analysis. | 37860916 | Zhong H, Liu S, Zhu J, Xu TH, Yu H, Wu L | Int J Cancer | 2024 | PLCO |
| Regulome-wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk. | 37850323 | Liu S, Zhong H, Zhu J, Wu Y, Deng Y, Wu L | Int J Cancer | 2024 | PLCO |
| Ultra-processed food consumption and risk of chronic respiratory diseases mortality among adults: evidence from a prospective cohort study. | 38413485 | Mekonnen TC, Melaku YA, Shi Z, Gill TK | Eur J Nutr | 2024 | PLCO |
| Dietary phytoestrogen intake and ovarian cancer risk: a prospective study in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort. | 38375679 | Song Y, Huang H, Jin M, Cheng B, Wang S, Yang X, Hu X | Carcinogenesis | 2024 | PLCO |
| Smoking, Drinking, and Dietary Risk Factors for Head and Neck Cancer in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Participants. | 38329760 | Lander DP, Kallogjeri D, Piccirillo JF | JAMA Otolaryngol Head Neck Surg | 2024 | PLCO |
| Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses. | 38350331 | Papadimitriou N, Qu C, Harrison TA, Bever AM, Martin RM, Tsilidis KK, Newcomb PA, Thibodeau SN, Newton CC, Um CY, Obón-Santacana M, Moreno V, Brenner H, Mandic M, Chang-Claude J, Hoffmeister M, Pellatt AJ, Schoen RE, Harlid S, Ogino S, Ugai T, Bucha… | EBioMedicine | 2024 | PLCO |
| Epidemiologic factors in relation to colorectal cancer risk and survival by genotoxic colibactin mutational signature. | 38252034 | Thomas CE, Georgeson P, Qu C, Steinfelder RS, Buchanan DD, Song M, Harrison TA, Um CY, Hullar MA, Jenkins MA, Van Guelpen B, Lynch BM, Melaku YA, Huyghe JR, Aglago EK, Berndt SI, Boardman LA, Campbell PT, Cao Y, Chan AT, Drew DA, Figueiredo JC, Fren… | Cancer Epidemiol Biomarkers Prev | 2024 | PLCO |
| Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival. | 37090539 | Georgeson P, Steinfelder RS, Harrison TA, Pope BJ, Zaidi SH, Qu C, Lin Y, Joo JE, Mahmood K, Clendenning M, Walker R, Aglago EK, Berndt SI, Brenner H, Campbell PT, Cao Y, Chan AT, Chang-Claude J, Dimou N, Doheny KF, Drew DA, Figueiredo JC, French AJ… | medRxiv | 2024 | PLCO |
| Doubly robust estimation of optimal treatment regimes for survival data using an instrumental variable. | Junwen, X., Zishu, Z. & Jingxiao, Z. | Stat Comput | 2024 | PLCO | |
| A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer. | 38554236 | Vermeulen R, Bodinier B, Dagnino S, Wada R, Wang X, Silverman D, Albanes D, Freedman N, Rahman M, Bell D, Chadeau-Hyam M, Rothman N | Eur J Epidemiol | 2024 | PLCO |
| Genetically Determined Circulating Lactase/Phlorizin Hydrolase Concentrations and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study. | 38542719 | Han S, Yao J, Yamazaki H, Streicher SA, Rao J, Nianogo RA, Zhang Z, Huang BZ | Nutrients | 2024 | PLCO |
| Fine particulate matter, noise pollution, and greenspace and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial Cohort. | 38497801 | Thomas AL, Rhee J, Fisher JA, Horner MJ, Jones RR | Cancer Epidemiol Biomarkers Prev | 2024 | PLCO |